Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease
about
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histologyIncreased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver DiseaseAdipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver DiseaseShaofu Zhuyu decoction ameliorates obesity-mediated hepatic steatosis and systemic inflammation by regulating metabolic pathwaysHepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease.HIF-1-alpha links mitochondrial perturbation to the dynamic acquisition of breast cancer tumorigenicity.Metabonomics Research Progress on Liver Diseases.Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.Hoxa5 undergoes dynamic DNA methylation and transcriptional repression in the adipose tissue of mice exposed to high-fat diet.Exploring the Process of Energy Generation in Pathophysiology by Targeted Metabolomics: Performance of a Simple and Quantitative Method.Novel circulating biomarkers for non-alcoholic fatty liver disease: A systematic review.Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample.A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.Inflammation, mitochondrial metabolism and nutrition: the multi-faceted progression of non-alcoholic fatty liver disease to hepatocellular carcinomaDiscovery of a novel calcium-sensitive fluorescent probe for α-ketoglutarate.An Electrochemical Enzyme Biosensor for 3-Hydroxybutyrate Detection Using Screen-Printed Electrodes Modified by Reduced Graphene Oxide and Thionine.Recent applications of gas chromatography with high-resolution mass spectrometry.CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment.
P2860
Q35783949-AC891976-DC47-417A-A576-DADF96A32E1AQ36001686-1CC6A572-A405-4AFF-BE86-A25E4367FAFAQ36126574-A94AAC3C-4236-4E4D-B6D6-C47C75601892Q36389547-1174E4A8-440B-43A9-A547-9799DE2F487FQ37166770-BC27C2B4-73C4-4996-A501-163AB0D0DC61Q37195735-574D858E-BD76-45FE-ABFF-2767C63B5BFFQ37376195-48F84416-36D3-4178-AED8-82A3C10B2470Q37683642-0905CE5C-665B-4D65-AF17-BFA75D4956C3Q38381079-9FC238A9-502E-469A-BEEF-8CB74AF0761FQ38449805-5C58CD09-901A-423F-A10C-6F065DF711A3Q38834406-ECC2C291-B01E-4F1B-B0C3-398975093461Q39072611-F45CF438-F483-461E-B933-F0F30C418CDFQ40257413-87E1CA55-6772-4381-A200-5A0817EE37C4Q41194816-A2C1572A-565C-44CC-A472-82BAAD566EECQ42380811-27F9E45A-D013-4FB1-B82E-E770DE158072Q46335142-BA34FF7E-8C04-4D45-9A23-51FAD1C9F98FQ47114994-64BB52F4-5E5A-41AE-84BC-7B003C180CB0Q48560174-40E05022-CE48-464A-A6D2-0CF47F10C00CQ55024109-B1AF2269-E446-422A-9DEF-0BD901D07C6CQ55323878-110F8793-BAAD-4A7F-8414-653D640591C3
P2860
Mapping of the circulating metabolome reveals α-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease
description
im März 2014 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 28 March 2014
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2014
@uk
name
Mapping of the circulating met ...... -alcoholic fatty liver disease
@en
Mapping of the circulating met ...... -alcoholic fatty liver disease
@nl
type
label
Mapping of the circulating met ...... -alcoholic fatty liver disease
@en
Mapping of the circulating met ...... -alcoholic fatty liver disease
@nl
prefLabel
Mapping of the circulating met ...... -alcoholic fatty liver disease
@en
Mapping of the circulating met ...... -alcoholic fatty liver disease
@nl
P2093
P2860
P50
P356
P1476
Mapping of the circulating met ...... -alcoholic fatty liver disease
@en
P2093
P2860
P2888
P304
P356
10.1038/IJO.2014.53
P407
P50
P577
2014-03-28T00:00:00Z